HomeCompareLIXTW vs SBUX

LIXTW vs SBUX: Dividend Comparison 2026

LIXTW yields 9049.77% · SBUX yields 2.75%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LIXTW wins by $20628078872155540.00M in total portfolio value
10 years
LIXTW
LIXTW
● Live price
9049.77%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20628078872155540.00M
Annual income
$20,189,225,229,131,710,000,000.00
Full LIXTW calculator →
SBUX
SBUX
● Live price
2.75%
Share price
$89.59
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$157.5K
Annual income
$65,840.13
Full SBUX calculator →

Portfolio growth — LIXTW vs SBUX

📍 LIXTW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLIXTWSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LIXTW + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LIXTW pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LIXTW
Annual income on $10K today (after 15% tax)
$769,230.77/yr
After 10yr DRIP, annual income (after tax)
$17,160,841,444,761,954,000,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$233.40/yr
After 10yr DRIP, annual income (after tax)
$55,964.11/yr
At 15% tax rate, LIXTW beats the other by $17,160,841,444,761,954,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LIXTW + SBUX for your $10,000?

LIXTW: 50%SBUX: 50%
100% SBUX50/50100% LIXTW
Portfolio after 10yr
$10314039436077770.00M
Annual income
$10,094,612,614,565,855,000,000.00/yr
Blended yield
97.87%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

LIXTW
No analyst data
Altman Z
-15.6
Piotroski
2/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+16.1% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LIXTW buys
0
SBUX buys
6
PoliticianChamberTickerTypeAmountDate
Shelley Moore Capito🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-28
Shelley Moore Capito🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-28
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Sheldon Whitehouse🏛 Senate$SBUX▼ Sell$1,001 - $15,0002026-01-09
Dan Newhouse🏢 House$SBUX▼ Sell$1,001 - $15,0002025-12-11
Ro Khanna🏢 House$SBUX▼ Sell$15,001 - $50,0002025-10-07
Ro Khanna🏢 House$SBUX▲ Buy$15,001 - $50,0002025-09-29
Ro Khanna🏢 House$SBUX▼ Sell$15,001 - $50,0002025-08-26
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLIXTWSBUX
Forward yield9049.77%2.75%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3%
Portfolio after 10y$20628078872155540.00M$157.5K
Annual income after 10y$20,189,225,229,131,710,000,000.00$65,840.13
Total dividends collected$20598825129197092.00M$127.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: LIXTW vs SBUX ($10,000, DRIP)

YearLIXTW PortfolioLIXTW Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$915,677$904,977.38$11,107$407.21+$904.6KLIXTW
2$78,425,318$77,445,542.82$12,512$626.87+$78.41MLIXTW
3$6,282,983,839$6,199,068,749.48$14,366$978.69+$6282.97MLIXTW
4$470,866,355,476$464,143,562,767.87$16,929$1,557.50+$470866.34MLIXTW
5$33,012,577,055,280$32,508,750,054,920.79$20,658$2,543.80+$33012577.03MLIXTW
6$2,165,414,967,816,058$2,130,091,510,366,908.20$26,406$4,302.22+$2165414967.79MLIXTW
7$132,896,851,494,306,460$130,579,857,478,743,280.00$35,877$7,622.00+$132896851494.27MLIXTW
8$7,631,926,324,796,117,000$7,489,726,693,697,209,000.00$52,741$14,352.64+$7631926324796.06MLIXTW
9$410,143,591,611,054,950,000$401,977,430,443,523,100,000.00$85,676$29,243.03+$410143591611054.88MLIXTW
10$20,628,078,872,155,540,000,000$20,189,225,229,131,710,000,000.00$157,513$65,840.13+$20628078872155540.00MLIXTW

LIXTW vs SBUX: Complete Analysis 2026

LIXTWStock

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to design novel compounds for serious common diseases. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures for the treatment of cancers, and vascular and metabolic diseases; and LB-200 series to treat chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group, as well as Netherlands Cancer Institute and Oncode Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.

Full LIXTW Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this LIXTW vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LIXTW vs SCHDLIXTW vs JEPILIXTW vs OLIXTW vs KOLIXTW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.